Scarica l'app Stockscreener
3.23
2.87%
0.09
Dopo l'orario di chiusura:
3.25
0.02
+0.62%
Glucotrack Inc Borsa (GCTK) Ultime notizie
Why Does Glucotrack (NASDAQ:GCTK) Stand Out This Session? - Kalkine Media
Glucotrack Strikes Settlement With Alto; $2M Cash Plus $2M Convertible Note at 5% - TradingView
Articles from Glucotrack - FinancialContent
Why Is the Market Watching Glucotrack? (NASDAQ:GCTK) - Kalkine Media
Lōkahi Therapeutics™ Expands ai² Into Three Opportunity-Creating Business Divisions - 01net
GlucoTrack Inc (GCTK) Key Financial Ratios – Valuation, Profitability & More - Value Research
Glucotrack (NASDAQ: GCTK) Announces White Lion Capital's 9.99% Stake Comprising 79,734 Shares - kalkinemedia.com
GlucoTrack Inc (GCTK) Peer Comparison – Compare with Others - Value Research
Near-10% Glucotrack (GCTK) holder faces ~5% cap unless limits raised - Stock Titan
Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Collaboration with San Diego State University Fowler College of Business - FinancialContent
Lōkahi Therapeutics Expands Ai2 Futures Lab Asset Origination Network Through Collaboration With San Diego State University Fowler College of Business - Moomoo
What Is Driving Glucotrack Stock? (NASDAQ:GCTK) - Kalkine Media
GlucoTrack Inc (GCTK) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Glucotrack (NASDAQ: GCTK) Executes 1-for-15 Reverse Stock Split, Reducing Shares to About 798,144 - Kalkine Media
What Is Driving Glucotrack Stock? - Kalkine Media
Glucotrack (GCTK) adds Lokahi merger statements and pro forma results - stocktitan.net
Glucotrack (NASDAQ: GCTK) reveals 90% Lokahi stake and going-concern warning - Stock Titan
GlucoTrack Announces 1-for-15 Reverse Stock Split - The Globe and Mail
Glucotrack Sets 1-for-15 Reverse Stock Split to Address Nasdaq Requirement - citybiz
Glucotrack announces 1-for-15 reverse split to reduce shares, CUSIP update, Nasdaq compliance goal - tradingview.com
Glucotrack to implement 1-for-15 reverse stock split Monday By Investing.com - Investing.com Nigeria
Glucotrack to implement 1-for-15 reverse stock split Monday - Investing.com
Lōkahi Therapeutics™ Initiates Clinical Trial Manufacturing for LT-100 - Yahoo Finance
Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Continued Collaboration with the University of Georgia - marketscreener.com
Form 8K GlucoTrack Inc For: 19 August By Investing.com - Investing.com Nigeria
Glucotrack shareholders approve director elections, reverse split, and warrant inducement - Investing.com
Glucotrack Shareholders Approve Up to 1-for-30 Reverse Stock Split - Minichart
Glucotrack (NASDAQ: GCTK) investors back reverse split, warrant deal - Stock Titan
Glucotrack, Inc. Approves the Election of Erik Emerson and Paul V. Goode to the Board of Directors - marketscreener.com
GlucoTrack Stock Short Interest Rises to 33.15% - Quiver Quantitative
GlucoTrack, Inc. (GCTK) Latest Stock News & Headlines - Yahoo Finance
Glucotrack Regains Nasdaq Equity Compliance as Strategic Transformation Advances - Yahoo Finance
Glucotrack regains Nasdaq compliance on equity requirement By Investing.com - Investing.com Canada
Glucotrack regains Nasdaq compliance on equity requirement - Investing.com
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation - Business Wire
GlucoTrack (GCTK) Edges Higher: Support at $0.35 Holds as Stock ConsolidatesPCR Mean Reversion - vinanet.vn
Glucotrack Company Profile & Introduction - Moomoo
Glucotrack Inc. (GCTK) narrows loss, warns on going concern and closes Lokahi deal - Stock Titan
GlucoTrack, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
GCTK|GlucoTrack Inc|Price:0.367|Chg%:+0.002 - TradingKey
GlucoTrack Inc (GCTK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
GlucoTrack Amends Equity Financing and Issues Commitment Shares - TipRanks
GlucoTrack Inc (GCTK) Stock News Today - tradingkey.com
GlucoTrack Secures New Financing to Support Growth - The Globe and Mail
Glucotrack Raises $5.5M as It Settles Into Its New Identity as an AI-Driven Biopharma Platform - biobuzz.io
E.F. Hutton Advises on $5.5 Million Financing for Glucotrack Subsidiary Lōkahi Therapeutics - citybiz
E.F. Hutton & Co. Acts as Exclusive Financial Advisor for $5.5 Million Financing for Glucotrack - The Manila Times
Glucotrack Secures $5.5 Million Financing With Premium Equity and Institutional Investment to Boost Growth - Minichart
Glucotrack Raises $5.5 Million Through Bridge Follow-On and Interim PIPE, Adds Registration Rights - TradingView
GlucoTrack, Inc. announced that it expects to receive $5.5 million in funding - marketscreener.com
Glucotrack Secures $5.5 Million Financing to Support Growth Strategy and Product Development - citybiz
Glucotrack Announces $5.5 Million Financing - marketscreener.com
14.67%
2.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):